Are you Dr. Jimeno?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12605 E 16th Ave
Aurora, CO 80045Phone+1 720-848-0000Fax+1 720-848-0360
Summary
- Dr. Antonio Jimeno, MD is an oncologist in Aurora, Colorado. He is currently licensed to practice medicine in Colorado. He is an Associate Professor at University of Colorado School of Medicine.
Education & Training
University of Valladolid Faculty of Medicine
Certifications & Licensure
CO State Medical License 2008 - 2025- CO State Medical License 2008 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Sacituzumab Govitecan in Patients with Relapsed/Refractory Advanced Head and Neck Squamous Cell Carcinoma: Results from the Phase II TROPiCS-03 Basket Study.Loren Michel, Antonio Jimeno, Ammar Sukari, J Thaddeus Beck, Joanne Chiu
Clinical Cancer Research. 2025-03-03 - NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.A Dimitrios Colevas, Anthony J Cmelak, David G Pfister, Sharon Spencer, Douglas Adkins
Journal of the National Comprehensive Cancer Network. 2025-02-01 - Histone-methyltransferase KMT2D deficiency impairs the Fanconi anemia/BRCA pathway upon glycolytic inhibition in squamous cell carcinoma.Wei Liu, Hongchao Cao, Jing Wang, Areeg Elmusrati, Bing Han
Nature Communications. 2024-08-08
Press Mentions
Microfluidic Pinch Technology May Treat Head and Neck Cancer: ResearchMarch 12th, 2023- Health News | Microfluidic Squeezing Technology Can Treat Head, Neck Cancer: ResearchMarch 12th, 2023
- Innovative Technology Again Promises Big PromisesMarch 4th, 2023
- Join now to see all
Grant Support
- Colorado Head and Neck Cancer SPOREUNIVERSITY OF COLORADO DENVER2021–2026
- Colorado Head and Neck Cancer SPOREUNIVERSITY OF COLORADO DENVER2021–2026
- Colorado Head and Neck Cancer SPOREUNIVERSITY OF COLORADO DENVER2021–2026
- Colorado Head and Neck Cancer SPOREUNIVERSITY OF COLORADO DENVER2021–2026
- Colorado Head and Neck Cancer SPOREUNIVERSITY OF COLORADO DENVER2021–2026
- Colorado Head and Neck Cancer SPOREUNIVERSITY OF COLORADO DENVER2021–2026
- Targeting oncogenic Myb fusions in salivary gland cancer with the elongation inhibitor SVC112UNIVERSITY OF COLORADO DENVER2021–2026
- Cancer Immunotherapy and Experimental Therapeutics - T32UNIVERSITY OF COLORADO DENVER2019–2025
